News Phase 1 Trial to Test AL002, Targeting Brain’s Immune System, as Way of Treating Alzheimer’s

News Comorbidities Common and Disabling in Alzheimer’s and Dementia Patients, UK Study Reports

News Beta-amyloid’s Key Role in Alzheimer’s Toxic Clumps and Need for Personalized Medicine Focus of Talk

News New Challenge Offers Scientists $4M in Prize Money to Find Cause of Alzheimer’s

News Chronic Inflammation May Underlie Higher Alzheimer’s Risk in ApoE4 Carriers, Study Shows

News Herpes Virus Increases Alzheimer’s Risk, but Antivirals May Be Effective Therapy, Review Study Reports

News Continued Physical Activity Benefits Older Adults at Risk of Alzheimer’s, Study Suggests

News Anavex 2-73 Slows Cognitive Decline in Alzheimer’s Patients, Phase 2 Extension Trial Shows

News Stem Cell Therapy Shows Evidence of Aiding Cognition, Lowering Amyloid Load in Mouse Model of Alzheimer’s

News CavoGene Pursues New Therapy for Neurodegenerative Diseases, Including Alzheimer’s

News Common Antidepressants May Prevent Beta-Amyloid Aggregates in Alzheimer’s, Study Reports

News Levels of Key Brain Antioxidant Linked to Alzheimer’s Can Be Monitored in Patients, Study Says

News Antibody Targeting Protein of Blood May Work Against Neurodegeneration, Study Reports

News Protein Involved in Calcium Transport in Nerve Cells Linked to Alzheimer’s in Early Study

News Alternations Seen in RNA Splicing and Protein Creation in Alzheimer’s Disease

News High Levels of Free Triiodothyronine Associated with Reduced Alzheimer’s Risk in Patients with Cognitive Impairment

News Dietary Supplement May Help Slow Alzheimer’s Progression and Improve Cognitive Outcomes, Small Trial Suggests

News Alzheimer’s Foundation Praises $425M Added to Combating Disease in HHS Budget

News Leukemia Therapy Sprycel May Potentially Treat Alzheimer’s Patients, Study Suggests

News Stroke Medicine May Prevent Early Nerve Cell Damage in Alzheimer’s, Mouse Study Finds

News Mitochondrial Gene May Protect Against Alzheimer’s, Other Aging-related Diseases, Study Reports

News Percentage of US Residents with Alzheimer’s to Double by 2060, CDC Reports

News New Strategy May Help Identify Those with Mild Cognitive Impairment at Risk to Develop Alzheimer’s

News Investigational Antibody IgG1-iS18 Reduces Amyloid Load, Improves Memory in Mice

News Efforts to Mark World Alzheimer’s Day, Sept. 21, and Month Are Well Underway

News Nuplazid More Effective in Reducing Severe Psychosis in Alzheimer’s, Trial Shows

News Age, Gender, and APOE4 Variant May Help Identify Those at High Risk for Dementia, Study Suggests

News Phase 3 Trial Results Suggest Flortaucipir Tracer Agent Can Help Predict Alzheimer’s Diagnosis

News Excessive Daytime Sleepiness Associated With Alzheimer’s Risk, Long-term Study Reports

News Peptide Found in Sea Anemones Might Give Rise to Alzheimer’s Treatment, Study Says

News Aducanumab Continues to Show Potential as Treatment for Mild Alzheimer’s in Long-term Extension of PRIME Trial

News Non-Invasive Eye Exam Might Help Predict Risk for Alzheimer’s, Study Suggests

News Synaptic Protein Makeup May Explain Why Not All People with Alzheimer’s Brain Markers Develop Dementia

News ProMIS’ PMN310 Shows Improved Safety Profile, Specificity Compared to Similar Alzheimer’s Candidates

News New Gene Variants Identified as Potential Risk Factors for Alzheimer’s

News Dysregulation of Iron Could Play a Central Role in Development of Early Onset Alzheimer’s

News Largest Genetic Database on Alzheimer’s Disease Will Soon Be Available to Researchers

News Preventive Treatment with Memantine May Halt Alzheimer’s Progression, Mouse Study Suggests

News Alzheimer’s Researchers Identify Biomarkers of Response to Anavex 2-73 Treatment

News Researchers Shed Light on Link Between Age and Dementia in Two Studies

News Bryostatin-1 Can Reverse Cognitive Decline in Moderate-to-Severe Alzheimer’s, New Data Shows

News Biohaven Enrolls 1st Patient in Phase 2/3 Trial of Trigriluzole for Mild to Moderate Alzheimer’s

News Genentech Presents Positive Data from Trials on Crenezumab and Gantenerumab for Alzheimer’s

News Aggressive Efforts to Lower Blood Pressure Also Drops Risk of Cognitive Impairment and Dementia, Trial Shows

News Dementia Among LGBT Adults in US Typical of General Public But Challenges May Be Greater, Report Notes

News Latest Trial Data Shows Potential of BAN2401 in Preventing Cognitive Decline in Early Alzheimer’s

News Ultrasound Wave Therapy Improves Cognition in Mouse Models of Alzheimer’s, Vascular Dementia

News New Test Directly Measures Loss of Synapses in Alzheimer’s Patients

News Research Targets Secret ‘Sulfate Code’ That Grants Bad Tau Protein Entry to Cells

News Process That Changes Tau Protein into Toxic Driver of Alzheimer’s Described in Study

News New Direction in Alzheimer’s Research May Help Identify Origin of Disease

News Investigational Therapy BAN2401 Slows Alzheimer’s Progression Over 18 Months, Phase 2 Results Show

News Low-dose Aspirin Seen to Reduce Amyloid Aggregates in Mouse Brains, Study Shows

News Alzheimer’s Risk Linked to Aging Made Worse by Diets High in Fats and Sugars, Study Shows

News New Research Challenges Current Beliefs on How Nerve Cells Die in Alzheimer’s Disease

News Alcohol Consumption Hinders Brain’s Ability to Clear Amyloid Beta, Early Study Reports

News Dementia Discovery Fund Collaborates with Immuneering to Discover New Alzheimer’s Therapies

News Tailored Light Exposure Improves Sleep, Mood, Behavior in Alzheimer’s Patients, Study Shows

News ProMIS Working to Move Antibody Treatment for Alzheimer’s into Clinical Trials

News Potential Alzheimer’s Treatment Targeting Bacteria Seen as Safe in Early Trial, Cortexyme Says

News Memory Training Tool Using Virtual Reality Available for Alzheimer’s Patients

News Phase 3 Trials of Lanabecestat in Alzheimer’s Patients Stopped for Lack of Efficacy, Eli Lilly and AstraZeneca Announce

News Red Sox Support Cure Alzheimer’s Fund, Disease Research at June Game Against Detroit Tigers

News Alzheimer’s Therapy Elenbecestat Reduces Brain Amyloid Levels, is Safe and Well-Tolerated, Trial Shows

News Responding to Common Myths About Alzheimer’s Disease

News Type 2 Diabetes Therapies May Help Relieve Alzheimer’s Symptoms, Researchers Say

News Cognition Therapeutics Awarded $6.6M to Support 2 Elayta Trials for Alzheimer’s

News Phase 1 Trial Assessing Stem Cell Therapy Recruiting Alzheimer’s Patients in Florida

News UsAgainstAlzheimer’s Launches AD PACE, New Patient-Caregiver Initiative

News Study Investigates ‘Friendsourcing’ as a Way to Provide Support to Alzheimer’s Caregivers

News Janssen Halts Clinical Development of Alzheimer’s Candidate Atabecestat Due to Liver Issues

News Phase 2 Trial Testing Alkahest’s Investigational GRF6019 for Alzheimer’s Doses First Patient

News Institute on Aging Awards $2.5M to Launch Collaborative Research Project

News Failed Verubecestat Trial May Call into Question Beta-amyloid Theory in Alzheimer’s, Study Suggests

News Phase 3 of Large-scale Alzheimer’s Disease Study Looking to Enroll Hundreds of Participants

News FDA Clearance Supports Start of Phase 2 Trial of TNX-102 SL for Agitation in Alzheimer’s Patients

News New Genetically Engineered Rat Model Can Aid Alzheimer’s Research, Study Says

News Biogen and Ionis Expand Collaboration to Develop Therapy Candidates for Alzheimer’s, Other Neurological Diseases

News Sleep Deprivation Leads to Accumulation of Protein Fragment Associated With Alzheimer’s

News First Stem Cell Therapy for Alzheimer’s Disease Approved, Applied in Japan

News Donation to Brown University Will Boost Research Into Brain Diseases

News Blood Test for Toxic Amyloid May Detect Alzheimer’s 8 Years Before Symptoms, Study Says

News ‘Prime of Life Brain Initiative’ Targets Neurodegenerative Diseases

News #AAN2018 – PRIME Trial Data Show Long-term Benefits of Aducanumab in Early Alzheimer’s

News #AAN2018: New Data Largely Supports Memantine Combo Easing Alzheimer’s Symptoms

News #AAN2018 – Early Data Supports Clinical Trial Now Testing IONIS-MAPTRx in Alzheimer’s Patients

News Chronic Exposure to Caffeine Worsened Symptoms in Alzheimer’s Mouse Model

News Researchers Using Natural Compound to ‘Beet’ Alzheimer’s Progression

News Spanish Regulators Approve Phase 2 Trial of Oryzon’s Alzheimer’s Therapy

News Increasing the Activity of Certain Type of Nerve Cell Restores Cognition, Mouse Study Shows

News Lyft Volunteers to Transport Alzheimer’s Patients to and from Clinical Trial Sites

News Niagen Treatment Leads to Improvements in Alzheimer’s Mouse Model, Study Reports

News Elayta Shows Potential for Improving Brain Cell Activity in Alzheimer’s, Trial Results Show

News Alzheimer’s Association Report Highlights Increases in Disease Prevalence and Cost of Care

News Neflamapimod Improves Episodic Memory in Early Alzheimer’s Patients in Phase 2a Trial

News Bryostatin Improves Cognition in Patients with Advanced Alzheimer’s, Analysis Finds

News Invicro Launches Algorithm that Helps Quantify Alzheimer’s Amyloid Plaques in PET Scans

News Phase 3 Trials of Gantenerumab Likely to Decide Clinical Benefit, Roche Says in Interview

News Four Europeans Share Nobel of Neuroscience for Research on Origins of Alzheimer’s

News Clairvoyant Unveils Theora Care for Caregivers to Connect with, Monitor People with Memory Loss, Alzheimer’s